Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arantxa Sancho-López
Observed names:
Arantxa Sancho Lopez,
Arantxa Sancho-Lopez
Institution:
Hospital Universitario Puerta de Hierro Majadahonda
Observed institutions:
European Medicines Agency,
Hospital Universitario Puerta de Hierro Majadahonda,
Agencia Española de Medicamentos y Productos Sanitarios
ORCID:
0000-0002-6192-4464
Observed ORCID:
0000-0002-6192-4464
OpenAlex ID:
A5023412833
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis
2022
·
Andrea B. Troxel
, Eva Petkova
, et al.
·
JAMA Network Open
·
72
PDF
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
2011
·
Zahra Hanaizi
, Barbara van Zwieten-Boot
, et al.
·
European Journal of Cancer
·
67
EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma
2018
·
Kyriaki Tzogani
, Elisabeth Penninga
, et al.
·
The Oncologist
·
29
PDF
The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2015
·
Zahra Hanaizi
, Beatriz Flores
, et al.
·
The Oncologist
·
26
PDF
The European Medicines Agency Review of Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Adult Men After Docetaxel Chemotherapy and in Chemotherapy-Naïve Disease: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2013
·
Iordanis Gravanis
, Arantxa Sancho Lopez
, et al.
·
The Oncologist
·
22
PDF
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis
2022
·
Antonio Gil-Nagel
, Mercè Falip
, et al.
·
Epilepsy & Behavior
·
20
The European Medicines Agency Review of Bosutinib for the Treatment of Adult Patients With Chronic Myelogenous Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
2014
·
Zahra Hanaizi
, Christoph Unkrig
, et al.
·
The Oncologist
·
16
The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy
2017
·
Kyriaki Tzogani
, Jorge Camarero Jiménez
, et al.
·
The Oncologist
·
14
PDF
The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)
2023
·
Arantxa Sancho-López
, Belén Ruiz-Antorán
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Early access to medicines in Spain: a retrospective hospital study with a proposal for a regulatory change
2026
·
Jose Porcel-Maleno
, Gerard Ronda-Roca
, et al.
·
Clinical & Translational Oncology
PDF
Longitudinal trends in the use of psychotropic medications in a Spanish pediatric population
2020
·
Inmaculada Palanca-Maresca
, Belén Ruiz-Antorán
, et al.
PDF
Show more works
View as search
Works count:
11
Citation count:
271
H-index:
8
I10-index:
8
Year
Topic
Type